Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-21-068300

Chief Commercial Officer bought 4,000 shares at $24.40 ($97,600)

From the SEC's structured data for this filing

Trades in this filing

Von Seggern Christopher · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-12-06 Purchase : show line 1 in the form +4,000 $24.40 $97,600 4,000 D
Open-market purchases · 4,000 sh · avg $24.40 · $97,600
Loading xslF345X03/doc4.xml…